Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Plos One|August 8, 2020
Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults​Kwai Han Yoo, Jinhyun Cho, Boram Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung CancerHaa-Na Song, Ki Sun Jung, Kwai Han Yoo, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 25, 2017
Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcomaChan Kim, Kwai Han Yoo, Min Hwan Kim, et al.
Cancer Research and Treatment|July 3, 2025
A Phase II Study of Daratumumab in Combination with Bortezomib and Dexamethasone in Patients with Multiple Myeloma Who Received One Prior Line of Therapy (KMM1906)Kwai Han Yoo, Sang Eun Yoon, Ka-Won Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2015
A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or ErlotinibJi Yun Lee, Jong-Mu Sun, Sung Hee Lim, et al.
Bone Marrow Transplantation|February 7, 2018
Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple studyKwai Han Yoo, Danbee Kang, Im-Ryung Kim, et al.
Annals of Hematology|December 20, 2019
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma reportJae-Cheol Jo, Seok Jin Kim, Ho Sup Lee, et al.
Translational Oncology|June 9, 2016
Genomic Alterations in Biliary Tract Cancer Using Targeted SequencingKwai Han Yoo, Nayoung K D Kim, Woo Il Kwon, et al.
Current Problems in Cancer|August 29, 2021
Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk featuresKwai Han Yoo, Dok Hyun Yoon, Hye Jin Kang, et al.
Annals of Hematology|July 1, 2023
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)Mihee Kim, Je-Jung Lee, Chang-Ki Min, et al.
Pageof 5